Castration-resistant prostate cancer (CRPC) marks the advanced and lethal stage of prostate cancer (PCa). TRIM28, also known as KAP1, is a transcriptional regulator recently shown to promote CRPC cell proliferation and xenograft tumor growth. Nonetheless, knowledge gaps persist regarding the mechanisms underlying TRIM28 upregulation in CRPC as well as the genomic targets regulated by TRIM28. Here, we report that TRIM28 is a E2F1 target in CRPC. Using an integrated genomic approach, we have demonstrated that TRIM28 forms a positive feedback loop to promote the transcriptional activation and genomic function of E2F1 independent of retinoblastoma (Rb) status. Furthermore, we identified RSK1 as a kinase that directly phosphorylates TRIM28 at S473, and, as such, RSK1 drives the TRIM28/E2F1 feedback loop. Accordingly, pS473-TRIM28 promotes CRPC progression, which is mitigated by RSK inhibition. In summary, our study reveals a critical role of the RSK1-TRIM28-E2F1 axis in CRPC progression, which may be exploited as a vulnerability in treating Rb-deficient CRPC.
RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression.
RSK1 驱动的 TRIM28/E2F1 反馈回路促进去势抵抗性前列腺癌的进展
阅读:8
作者:Kim Miyeong, Liu Jinpeng, Zhang Yanquan, Wang Ruixin, Goettl Ryan, Grasso Jennifer, Allison Derek B, Wang Chi, Gao Tianyan, Liu Xiaoqi, Fong Ka-Wing
| 期刊: | Journal of Clinical Investigation | 影响因子: | 13.600 |
| 时间: | 2025 | 起止号: | 2025 Jun 16; 135(12):e185119 |
| doi: | 10.1172/JCI185119 | 研究方向: | 肿瘤 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
